Skip to main content

Free Content Incidence of tuberculosis after HAART initiation in a cohort of HIV-positive patients in Burkina Faso

Download Article:
(PDF 256.16015625 kb)


OBJECTIVE: To determine the incidence rates of tuberculosis (TB) after the initiation of highly active antiretroviral treatment (HAART).

METHODS: We conducted a retrospective cohort study on four human immunodeficiency virus (HIV) treatment centres in Ouagadougou, Burkina Faso. TB incidence was measured at different intervals after HAART initiation. Cox regression models were used to identify factors associated with TB incidence.

RESULTS: We analysed a cohort of 2383 subjects with a mean follow-up period of 836 days (standard deviation ± 443.4). TB incidence rate was highest during the first trimester of HAART; after 3 months of treatment, the total TB case incidence dropped by 60% from 5.77/100 person-years (py) to 2.23/100 py. World Health Organization clinical Stage III or IV, CD4+ T-cell count < 50 cells/μl and body mass index (BMI) < 18.5 were associated with increased risk of TB on univariate analysis. In the Cox regression, BMI < 18.5 and CD4+ T-cell count < 50 cells/μl at HAART initiation were independently associated with a two-fold higher risk of TB.

CONCLUSIONS: Delaying HAART initiation until the CD4+ T-cell count drops to <50 cells/μl significantly increases TB incidence in the first 3 months after HAART initiation. Active case finding for TB is an essential element of standard clinical care in HIV-positive patients during the initial period of HAART.

Keywords: HAART; HIV infection; incidence; tuberculosis

Document Type: Regular Paper

Affiliations: 1: National Tuberculosis Programme, Ministry of Health, Ouagadougou, Burkina Faso 2: National Tuberculosis Programme, Ministry of Health, Ouagadougou, Burkina Faso; and Infectious and Tropical Diseases Institute, University of Brescia, Brescia, Italy 3: Infectious and Tropical Diseases Institute, University of Brescia, Brescia, Italy 4: Médecins Sans Frontières HIV/AIDS Treatment Centre, Ouagadougou, Burkina Faso 5: Red Cross Ambulatory for HIV/AIDS Treatment, Ouagadougou, Burkina Faso 6: African Solidarity Association, Ouagadougou, Burkina Faso 7: Bio-Molecular Research Centre, Centre de Recherche Biomoléculaire Pietro Annigoni, Ouagadougou, Burkina Faso

Publication date: 2010-03-01

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease publishes articles on all aspects of lung health, including public health-related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research. The IJTLD is dedicated to the continuing education of physicians and health personnel and the dissemination of information on tuberculosis and lung health world-wide.

    Certain IJTLD articles are selected for translation into French, Spanish, Chinese or Russian. They are available on the Union website

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more